Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Joint Bone Spine
Volume 73, n° 3
pages 231-233 (mai 2006)
Doi : 10.1016/j.jbspin.2005.10.014
Received : 11 May 2005 ;  accepted : 21 June 2005
Medical benefits from drugs
 

Gilles Bouvenot a, b
a President of the Transparency Commission, The French National Authority for Health, Saint Denis, France 
b Internal Medicine and Therapeutics Department, Sainte Marguerite Hospital, 270 Boulevard Sainte-Marguerite, 13274 Marseille cedex 9, France 


Keywords : French National Authority for Health, Drug evaluation, Drug reimbursement, French committee for assessment of medicinal products




© 2006  Elsevier SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@